Copyright © 2012 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539
A Call for Completion of Randomized Clinical Trials A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory. Journal of the American College of Cardiology . © 2009 by the American Heart Association, Inc., and the American College of Cardiology Foundation
Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 2010 1941-7632
Copyright © 2009 American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 2009 1941-7632
Copyrigh © 2011 American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 2011 1941-7632
Copyright © 2010 American Heart Association. All rights reserved. Print ISSN: 1941-7640. Online ISSN: 2010 1941-7632
This editorial refers to ‘Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry’†, by H. Eltchaninoff et al. on page 191 and ‘Transcatheter aortic valve implantation: first results from a multi-centre real-world registry’‡, by R. Zahn et al. on page 198. Published on behalf of the European Society of Cardiology. All rights reserved. Copyright The Author 2010. The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Aims Transcatheter aortic valve implantation is a therapeutic alternative for high-surgical-risk patients with severe symptomatic aortic stenosis. Two models of prosthesis are currently commercialized in France, which can be implanted either via a transarterial or a transapical approach. The aim of the study was to evaluate in a national French registry the early safety and efficacy of transcatheter aortic valve replacement (AVR) using either the Edwards SAPIEN™ or CoreValve™ in high-surgical-risk patients with severe aortic stenosis. Published on behalf of the European Society of Cardiology. All rights reserved. Copyright The Author 2010.
Aims The Medtronic Engager™ aortic valve bioprosthesis is a self-expanding valve with support arms facilitating anatomically correct positioning and axial fixation. Valve leaflets, made of bovine pericardium, are mounted on a Nitinol frame. Here, we report the first in man study with this new implant (Trial Identifier NCT00677638). Published on behalf of the European Society of Cardiology. All rights reserved. Copyright The Author 2010.
Aims Dysfunction of valved conduits in the right ventricular outflow tract (RVOT) limits durability and enforces repeated surgical interventions. We report on our combined two-centre experience with percutaneous pulmonary valve implantation (PPVI). Published on behalf of the European Society of Cardiology. All rights reserved. Copyright The Author 2011.
The authors sought to define the impact of paclitaxel-coated balloon angioplasty for treatment of drug-eluting stent restenosis compared with uncoated balloon angioplasty alone. Journal of the American College of Cardiology Vol. 59, No. 15, 2012 © 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc.
Aims: To compare primary percutaneous coronary intervention (pPCI) and fibrinolysis in very old patients with ST-segment elevation myocardial infarction (STEMI), in whom head-to-head comparisons between both strategies are scarce. Published on behalf of the European Society of Cardiology. European Heart Journal (2011) 32, 51–60. All rights reserved. Copyright The Author 2010.
AIM: To study a cohort of consecutive patients undergoing transcatheter aortic valve implantation (TAVI) and compare the outcomes of atrial fibrillation (AF) patients vs patients in sinus rhythm (SR). World J Cardiol. January 26, 2012. Volume 4. Copyright © 2012 Baishideng. All rights reserved.
Warfarin acts by inhibiting the enzymes involved in the formation of a reduced form of vitamin K, which is essential for γ-carboxylation of glutamate residues at the amino terminus of coagulation factors Ⅱ, Ⅶ, Ⅸ and Ⅹ and anticoagulant factors protein C and S. This results in production of partially carboxylated, biologically inactive clotting factors. World J Cardiol 2012 March 26; 4(3): 54-59. Copyright © 2012 Baishideng. All rights reserved
We report a novel technique for percutaneous removal of the right heart thrombi using a suction cannula. This method allowed complete en bloc removal of the right atrial thrombus avoiding surgical procedure in a high risk patient. Copyright 2011 Wiley Periodicals, Inc. Catheterization and Cardiovascular Interventions 79:344–347 (2012)
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos